Home › Funds › Citigroup Inc › ORMP
Citigroup Inc position in ORMP
ORAMED PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)15.81K sh
Reported value held$76.04K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.44K | $76.00K | New |
| Q4 2021 | 8.28K | $118.00K | Add |
| Q1 2022 | 2.44K | $21.00K | Reduce |
| Q2 2022 | 3.58K | $16.00K | Add |
| Q3 2022 | 30.64K | $199.00K | Add |
| Q4 2022 | 65.89K | $792.66K | Add |
| Q1 2023 | 25.06K | $54.62K | Reduce |
| Q2 2023 | 37.44K | $134.05K | Add |
| Q3 2023 | 41.47K | $108.24K | Add |
| Q3 2025 | 4 | $11 | New |
| Q1 2026 | 8.99K | $30.56K | New |
| Q2 2026 | 15.81K | $76.04K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORMP
- BlackRock Inc 1.61M sh · $7.74M · Q2 2026
- Geode Capital Management 500.69K sh · $2.41M · Q2 2026
- Goldman Sachs Group 253.29K sh · $1.22M · Q2 2026
- Northern Trust Corp 184.92K sh · $889.47K · Q2 2026
- Renaissance Technologies 183.80K sh · $884.08K · Q2 2026
- Wells Fargo & Co 166.00K sh · $798.46K · Q2 2026
- Bank of America Corp 150.69K sh · $724.84K · Q2 2026
- Marshall Wace 101.95K sh · $490.39K · Q2 2026
- Charles Schwab Investment Management 83.63K sh · $402.28K · Q2 2026
- BNY Mellon 79.25K sh · $381.22K · Q2 2026
- UBS Group AG 67.67K sh · $325.50K · Q2 2026
- Morgan Stanley 43.36K sh · $208.55K · Q2 2026